Category Archives: C Diff Foundation

Pharmaceutical Patient Assistance Program Information

Have you ever seen a TV ad for a prescription that concluded with “If you can’t afford your prescription medicine, Astra-Zeneca (or Pfizer or AbbVie) may be able to help you” and wondered what that meant? If you have commercial health insurance, that might mean a discount card to lower your co-pay to something more affordable. For patients, without health insurance, it could mean a free or discounted prescription, if you know how to access the Patient Assistance Programs sponsored by many pharmaceutical companies.

Many pharmaceutical companies have created Patient Assistance Programs, or PAPs, to provide select brand-name prescriptions at no cost to those patients that meet their financial and insurance criteria. The programs rely on healthcare providers or their staff to submit patient health and financial information, sometimes as often as every 90 days, so patients can receive life-saving prescriptions at no cost to them. Each specific program has its own set of eligibility rules which the patient must meet to be considered for free medications. While a few PAP medications are sent directly to the patient’s home, most are sent to their healthcare provider.

“We have a number of patients that contact us directly from the hospital or have not seen a doctor for many years”, said Nancy Caralla, Executive Director, C Diff Foundation. “By the time they contact us, they tend to have multiple conditions, some advanced, requiring some of the newer and more advanced therapies. Fortunately, those therapies are the ones that are usually available through Patient Assistance Programs.”

Through the affordable pharmaceutical lists provided by Walmart Pharmacy and the GoodRx App. we have also been successful in assisting patients with generic medication information or assistance program availability.

“None of us can do this alone ~ All of us can do this together.”

 

C diff and You app. Available From the Apple Store and Get It On Google

C diff and You

Available From Apple Store and
Get It On Google

Eliminate the hours spent searching for
C. diff. infection information, definitions, and more on the web. Patients, with family members, caregivers,  and friends, are overwhelmed, and absolutely exhausted.

 

 

No one diagnosed with a CDI, and feeling so poorly,  has the time or energy to sit in front of a computer searching, reading, and clicking through pages of information.

Stay connected, stay up-to-date with the C Diff Foundation.

“None of us can do this alone ~ All of us can do this together.”

Download C diff and You today to learn more about
C. diff. (Clostridioides difficile, C. difficile, CDI) infection prevention, treatments, clinical trials, support, environmental safety, and more.

Members of the Junior Infection Fighters Program Are Introduced to an Infection Prevention Study Lead by Key Healthcare Professionals

During the past months of turbulent times and sheer confusion caused by the COVID-19 global pandemic, we look forward to sharing a ray of sunshine whenever possible.

Today we are pleased to share the following published Abstract in the
American Journal of Infection Control by APIC

Engaging Middle School Children in the C Diff Foundation’s Junior Infection Fighters Program

https://www.ajicjournal.org/article/S0196-6553(20)30466-1/pdf

Our profound gratitude to:

Teena Chopra, MD, MPH, Co-Director Medical Education Junior Infection Fighters Program

Maureen Spencer, M. Ed, BSN, RN, CIC, FAPIC, Co-Director Medical Education Junior Infection Fighters Program

Dayle Skelly, BA, C. diff. Survivor, Director Junior Infection Fighters Program

A stellar example of teamwork in coordinating the study, developing educational material, and introducing the children to educational activities focused on healthy-habits and preventing infections.


“None of us can do this alone ~ All of us can do this together.”


We express our gratitude and applaud all who have continued to demonstrate their professional skills, leadership, tireless efforts, and unfailing dedication in areas of specialization and even more so during these unprecedented times.

We are more than grateful to those who forge ahead for the sake of others in need seeking medical care and resolution of this life-threatening infection.

Wishing you good health and continued success.

In gratitude,

Nancy
Nancy C Caralla
Founding President, Executive Director

The 4th Annual Global C. diff. Awareness 2K Walks Go Virtual on September 11 and 12

The 4th Annual Global C.diff. Awareness 2K Walks Will Now Be VIRTUAL!

                   Join Us On……………….

Friday, September 11th – UK

Dr. Clokie, UK Walk Event Coordinator, will be hosting the VIRTUAL Walk in Leicester on September 11th as the UK is also under strict guidelines to slow the spread of the COVID-19 virus. 

  • The Leicester VIRTUAL Walk Will Begin at 10:00 a.m. – 11:00 a.m. – UK

  • VIRTUAL Entertainment Will Begin at 10:00 a.m. UK For the Children!

Saturday, September 12th –  USA

  • The VIRTUAL Walks Will Begin at 9:00 a.m. through 12:00 p.m. EDT

  • VIRTUAL Entertainment Will Begin at 9:00 a.m. EDT For the Children!

All Registered Awareness Walkers Will Receive a T-Shirt, Giveaways, and More via: United States Postal Service To the Address Provided at the Time Of Registration.

To Learn More About the Global C. diff. Awareness Walk Event and How You Can Register, Please Click On the Green Button Below……………..

 

 

 

We are truly grateful for your efforts, support and participation
of the Annual Walk events and we look forward to virtually walking with you in September!

“None of us can do this alone ~ All of us can do this together!”
~ C Diff Foundation

C Diff Foundation Welcomes Glenn Tillitson, PhD, FIDSA, FRSM, FCCP, FISC Co-Chair, Infection Prevention and Control Committee

We are pleased to welcome Dr. Glenn Tillitson,  PhD, FIDSA, FRSM, FCCP, FISC as a Member of the C Diff Foundation, Co.-Chair of the Infection Prevention and Control Committee, (Non-Executive Director).

Glenn has over 30 years in experience in global infectious disease and with a focus in anti-infective drug development and medical educational and medical affairs. Glenn has written many publications in the various aspects of ID (>150 papers on PubMed with a further >40 not cited). Demonstrated capabilities in broad-ranging educational initiatives aimed at improving patient health. Glenn has published multiple publications and an e-book on C difficile.  Recently he has been active in developing new products for Clostridium difficile, MRSA and MDR Gram-negative infections. Built and led a medical affairs team to prepare for the approval and launch of a fourth-generation macrolide for use in pneumonia. Most recently played a role in the approval of cefiderocol ,a novel siderophore cephalosporin, in the US.

We look forward to Dr. Tillitson collaborating with members of the Infection Prevention and Control Committee to develop continued strategy for Infection Prevention & Control and to join the decision making IPC committee members to ensure that the Infection Prevention & Control Annual Conference Program material is agreed, developed and implemented for the good of fellow-healthcare professionals worldwide.